"Designing Growth Strategies is in our DNA"
Radiodermatitis is the skin condition observed in the patients undergoing radiation therapy used for the treatment of cancer or other skin conditions. The general symptoms associated with radiation burns include itching, redness, flaking, peeling, soreness, blisters, and others. Radiodermatitis can be either acute or chronic and can be categorized into four grades of severity, namely redness, peeling, swelling, and death of skin cells. Radiodermatitis can be very painful for cancer patients.
There are many oral medicines and ointments that are available for Radiodermatitis treatment. Hydrogel, silver lea and other types of dressing are also being used to treat radiodermatitis. In December 2016, Helsinn Healthcare SA received FDA approval for the use of Xonrid Gel, topical therapy for Radiodermatitis in the USA. Growing demand for effective treatment options further enhancing the quality of life patient is likely to boost the global Radiodermatitis market during the forecast period.
To gain extensive insights into the market, Request for Customization
Growing investments in the research domain in developing effective therapies in the curing radiodermatitis and increasing incidences of radiodermatitis in cancer patients are likely to drive the growth of radiodermatitis market during the forecast period. In 2018, according to the World Health Organization (WHO), the total number of cancer cases in the world were around 18.1 million and is estimated to reach 29.5 million by 2040, further augmenting the growth of the global radiodermatitis market.
However, high risk of exposure to radiation to non-target areas because of which people tend to avoid radiation therapy is a major factor that can hinder the growth in global radiodermatitis market during the forecast period.
Some of the major companies that are present in the global radiodermatitis market are 3M, Mölnlycke Health Care AB, KCI Licensing Inc., Smith & Nephew, Stratpharma AG, Helsinn Healthcare SA, and others.
Hydrogel & Hydrocolloid Dressing
No-Sting Barrier Film
Silver Leaf Dressing
Silicone Coated Dressings
Honey Impregnated Gauze
By Route of Administration
By Distribution Channel
· Cancer Specialist Clinics
· Research Institutes
· North America (U.S. and Canada)
· Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
· Latin America (Brazil, Mexico, and Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)
Among Route of administration segmentation, the topical segment is anticipated to hold the largest radiodermatitis market share during the forecast duration owing to the new product launches, ease of applications, and generating fast results. In July 2017, Stratpharma AG, a company specialized in manufacturing of topical products, launched StrataXRT a topical wound dressing for radiation dermatitis.
The global radiodermatitis market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to dominate the radiodermatitis market during the forecast period owing to the increase in the prevalence of cancer and the dominant use of radiation therapy as a treatment option for various types of cancer. According to the National Cancer Institute (NCI), in 2018, approximately 1,735,350 new cases of cancer were expected to be diagnosed in the U.S. which is likely to increase the demand for the therapies for the treatment of radiodermatitis. The growth of radiodermatitis market is likely to expand at a significant rate in the Asia Pacific region, due to the increasing government awareness programs educating about the available treatment options to cure dermatitis in cancer patients, and growing investments in improving healthcare infrastructure.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry